A subset of chronic eosinophilic leukemia (CEL) patients bears mutated and/or fused forms of PDGFRα, which is a receptor TK targeted by ponatinib. The gene discussed is PDGFRA; the disease is Chronic Eosinophilic Leukemia, Not Otherwise Specified.